loadpatents
name:-0.019624948501587
name:-0.0090129375457764
name:-0.0035269260406494
Lehmann; Fredrik Patent Filings

Lehmann; Fredrik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lehmann; Fredrik.The latest application filed is for "novel formulations comprising melflufen".

Company Profile
3.10.16
  • Lehmann; Fredrik - Stockholm SE
  • Lehmann; Fredrik - Knivsta SE
  • Lehmann; Fredrik - Uppsala SE
  • Lehmann; Fredrik - Sigtuna SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Formulations Comprising Melflufen
App 20220184021 - Lehmann; Fredrik ;   et al.
2022-06-16
Lyophilized preparation of cytotoxic dipeptides
Grant 11,344,622 - Spira , et al. May 31, 2
2022-05-31
Compounds
App 20220106349 - Gardarsson; Fridrik Runar ;   et al.
2022-04-07
Azithromycin derivatives with epithelial barrier enhancement properties
Grant 11,236,120 - Gardarsson , et al. February 1, 2
2022-02-01
Compounds Containing Deuterium
App 20210388024 - Lehmann; Fredrik
2021-12-16
Lyophilized preparation of cytotoxic dipeptides
Grant 10,869,928 - Spira , et al. December 22, 2
2020-12-22
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20200345848 - SPIRA; Jack ;   et al.
2020-11-05
Azithromycin Derivatives With Epithelial Barrier Enhancement Properties
App 20200317710 - Gardarsson; Fridrik Runar ;   et al.
2020-10-08
Azithromycin derivatives with epithelial barrier enhancement properties
Grant 10,723,752 - Gardarsson , et al.
2020-07-28
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20200121794 - SPIRA; Jack ;   et al.
2020-04-23
Lyophilized preparation of cytotoxic dipeptides
Grant 10,543,274 - Spira , et al. Ja
2020-01-28
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20200009252 - SPIRA; Jack ;   et al.
2020-01-09
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20190240332 - SPIRA; Jack ;   et al.
2019-08-08
Lyophilized preparation of cytotoxic dipeptides
Grant 10,322,182 - Spira , et al.
2019-06-18
Lyophilized preparations of melphalan flufenamide
Grant 10,285,947 - Spira , et al.
2019-05-14
Lyophilized preparations of melphalan flufenamide
Grant 10,285,946 - Spira , et al.
2019-05-14
Azithromycin Derivatives With Epithelial Barrier Enhancement Properties
App 20180354981 - Gardarsson; Fridrik Runar ;   et al.
2018-12-13
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20170049894 - SPIRA; Jack ;   et al.
2017-02-23
Lyophilized Preparations Of Melphalan Flufenamide
App 20160271065 - SPIRA; Jack ;   et al.
2016-09-22
Lyophilized Preparations Of Melphalan Flufenamide
App 20150335578 - SPIRA; Jack ;   et al.
2015-11-26
Lyophilized Preparation Of Cytotoxic Dipeptides
App 20140128462 - Spira; Jack ;   et al.
2014-05-08
Novel Compounds, Use And Preparation Thereof
App 20130203774 - Jensen; Annika Jenmalm ;   et al.
2013-08-08
Amino substituted pyrazines as inhibitors or protein kinases
Grant 8,436,171 - Jensen , et al. May 7, 2
2013-05-07
Novel Compounds, Use And Preparation Thereof
App 20110098310 - Jensen; Annika Jenmalm ;   et al.
2011-04-28
UII-modulating compounds and their use
App 20070043104 - Luthman; Ingrid Kristina ;   et al.
2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed